21/04-2017 16:51:44: (BIOPOR.CPH) BioPorto.s Annual General Meeting
BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides
healthcare professionals in clinical and research settings a range of
diagnostic tests and antibodies. Our pioneering product portfolio includes
assays for underserved disease states such as NGAL for acute kidney injury.
BioPorto has its headquarters in Copenhagen, Denmark and is listed on the
Nasdaq Copenhagen stock exchange.icy and Guidelines for
-- Proposal for renewal of the authorization to issue convertible bonds.
Thomas Magnussen, Torben A. Nielsen and Niels Christian Nielsen offered
themselves for re-election and were re-elected. In addition, Kirsten Drejer was
elected as a new board member. Immediately after the Annual General Meeting,
the Board of Directors elected Thomas Magnussen as its chairman and Torben A.
Nielsen as its vice chairman.
PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab was re-elected
as the Company.s auditor.
Hellerup, April 21, 2017
The Board of Directors
For further information, please contact:
Peter Morch Eriksen, CEO
Gry Husby Larsen, General Counsel
Telephone +45 45 29 00 00,BioPorto A/S
Decisions of general meeting
BioPorto.s Annual General Meeting
BioPorto A/S held its Annual General Meeting today where the shareholders
approved the report on the Company.s activities and adopted the 2016 Annual
Report. In addition, the Annual General Meeting adopted the proposed
profit/loss allocation and discharge was given to the Board of Directors and
the Management Board. Finally, the remuneration of the Board of Directors was
Proposals from the Board of Directors in Item 6 of the agenda were adopted as
-- Proposal for the annual report and interim reports to be prepared and
presented in English.
-- Proposal for company announcements to be prepared and published in English.
-- Proposal for approval of Remuneration Pol
Ekstern link: https://cns.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=769601&messageId=966556
Ekstern link: https://cns.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=626387
Nyheten er levert av OMX.